ORGO FY 2023 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$355M

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$433M-3.9% YoY

Gross Profit

$327M75.4% margin

Operating Income

$13M2.9% margin

Net Income

$5M1.1% margin

EPS (Diluted)

$0.04

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$7M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$460M

Total Liabilities

$181M

Stockholders' Equity

$279M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$433M	$451M	-3.9%
Gross Profit	$327M	$346M	-5.6%
Operating Income	$13M	$22M	-43.8%
Net Income	$5M	$16M	-68.2%